What is Myriad Genetics's debt issuance proceeds?

Myriad Genetics (MYGN) reported debt issuance proceeds of $0 in Q1 2026.

How has Myriad Genetics's debt issuance proceeds changed year-over-year?

Myriad Genetics's debt issuance proceeds decreased by 100.0% year-over-year, from $40M to $0.

What does debt issuance proceeds mean?

Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.

Myriad Genetics MYGN Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Quest DiagnosticsDGX

$0-100%

Guardant HealthGH

$100.63M—

Tempus AI, Inc.TEM

$0-100%

BillionToOne, Inc. BLLN

$30M—

Opko HealthOPK

$8.49M+51.3%

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's debt issuance proceeds?: Myriad Genetics (MYGN) reported debt issuance proceeds of $0 in Q1 2026.
How has Myriad Genetics's debt issuance proceeds changed year-over-year?: Myriad Genetics's debt issuance proceeds decreased by 100.0% year-over-year, from $40M to $0.
What does debt issuance proceeds mean?: Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.